These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 34217413)

  • 1. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.
    Walker MJ; Meggetto O; Gao J; Espino-Hernández G; Jembere N; Bravo CA; Rey M; Aslam U; Sheppard AJ; Lofters AK; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Rabeneck L
    Prev Med; 2021 Oct; 151():106586. PubMed ID: 34217413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
    Meggetto O; Jembere N; Gao J; Walker MJ; Rey M; Rabeneck L; Murphy KJ; Kupets R;
    BJOG; 2021 Aug; 128(9):1503-1510. PubMed ID: 33982870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
    El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
    Elife; 2023 Jun; 12():. PubMed ID: 37377399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical screening during the COVID-19 pandemic: optimising recovery strategies.
    Castanon A; Rebolj M; Burger EA; de Kok IMCM; Smith MA; Hanley SJB; Carozzi FM; Peacock S; O'Mahony JF
    Lancet Public Health; 2021 Jul; 6(7):e522-e527. PubMed ID: 33939965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic.
    Walker MJ; Wang J; Mazuryk J; Skinner SM; Meggetto O; Ashu E; Habbous S; Nazeri Rad N; Espino-Hernández G; Wood R; Chaudhry M; Vahid S; Gao J; Gallo-Hershberg D; Gutierrez E; Zanchetta C; Langer D; Zwicker V; Rey M; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Singh S; Warde P; Forbes L; Dobranowski J; Irish J; Rabeneck L;
    JAMA Netw Open; 2022 Apr; 5(4):e228855. PubMed ID: 35467731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
    Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
    Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities.
    Wentzensen N; Clarke MA; Perkins RB
    Prev Med; 2021 Oct; 151():106596. PubMed ID: 34217415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada.
    Malagón T; Yong JHE; Tope P; Miller WH; Franco EL;
    Int J Cancer; 2022 Apr; 150(8):1244-1254. PubMed ID: 34843106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects.
    Fisher-Borne M; Isher-Witt J; Comstock S; Perkins RB
    Prev Med; 2021 Oct; 151():106681. PubMed ID: 34217422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Cremation Data for Timely Mortality Surveillance During the COVID-19 Pandemic in Ontario, Canada: Validation Study.
    Postill G; Murray R; Wilton AS; Wells RA; Sirbu R; Daley MJ; Rosella L
    JMIR Public Health Surveill; 2022 Feb; 8(2):e32426. PubMed ID: 35038302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study.
    Chiarelli AM; Walker MJ; Espino-Hernandez G; Gray N; Salleh A; Adhihetty C; Gao J; Fienberg S; Rey MA; Rabeneck L
    CMAJ Open; 2021; 9(4):E1205-E1212. PubMed ID: 34933878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional survey of the impact of the COVID-19 pandemic on cancer screening programs in selected low- and middle-income countries: Study from the IARC COVID-19 impact study group.
    Villain P; Carvalho AL; Lucas E; Mosquera I; Zhang L; Muwonge R; Selmouni F; Sauvaget C; Basu P;
    Int J Cancer; 2021 Jul; 149(1):97-107. PubMed ID: 33533501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Landscape Assessment of Colorectal Cancer Screening during the COVID-19 Pandemic.
    El Bizri M; Hamidi MW; Mksyartinian P; Stein BD
    Curr Oncol; 2023 Oct; 30(10):8973-8991. PubMed ID: 37887548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Short-Term Impact Of COVID-19 Pandemic on Cervical Cancer Screening: A Systematic Review and Meta-Analysis.
    Sasidharanpillai S; Ravishankar N
    Asian Pac J Cancer Prev; 2022 May; 23(5):1497-1504. PubMed ID: 35633530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using geographic methods to inform cancer screening interventions for South Asians in Ontario, Canada.
    Lofters AK; Gozdyra P; Lobb R
    BMC Public Health; 2013 Apr; 13():395. PubMed ID: 23622426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding those overdue for cancer screening by five years or more: A retrospective cohort study in Ontario, Canada.
    Lofters AK; Kopp A; Vahabi M; Glazier RH
    Prev Med; 2019 Dec; 129():105816. PubMed ID: 31445111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.